Gurleen Kaur/X
Aug 22, 2025, 14:56
Lipoprotein(a) as a Prognostic Marker in Atherosclerotic Vascular Disease: Insights from UK Biobank Study
Gurleen Kaur, Cardiology Fellow at Brigham and Women’s Hospital, shared a post on X:
“In this Original Research paper in CircAHA, Bellamo et al evaluate Lp(a) as a prognostic marker for incident and secondary vascular disease in participants from the UK Biobank.
Here’s a summarizing key aspects of paper. Let’s unpack the findings.”
Title: Evaluation of Lipoprotein(a) as a Prognostic Marker of Extracoronary Atherosclerotic Vascular Disease Progression
Authors: Tiffany R. Bellomo, Emily E. Bramel, Jiwoo Lee, Sarah Urbut, Alyssa Flores, Zhi Yu, Satoshi Koyama, Buu Truong, Sara Haidermota, Matthew J. Eagleton, Pradeep Natarajan, and Aniruddh P. Patel

Read the full article here.
Stay informed with Haemostasis Today.
Alyssa Flores
Aniruddh P. Patel
Atherosclerosis
Atherosclerotic Vascular Disease
Buu Truong
Emily E. Bramel
Hematology
Hemostasis
Hemostasis Today
Jiwoo Lee
Lipoprotein(a)
Matthew J. Eagleton
Pradeep Natarajan
Prognostic Marker
Sara Haidermota
Sarah Urbut
Satoshi Koyama
Tiffany R. Bellomo
UK Biobank
Zhi Yu
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning